Neoantigen-reactive CD4 T cells have also been shown to mediate clinical regression in a patient with cholangiocarcinoma when neoantigen-reactive CD4 T cells were adoptively transferred (39), further confirming the important contribution of neoantigen-specific CD4 T cells towards antitumor immunity. The gene discussed is CD4; the disease is cholangiocarcinoma.